Barbara Gayle Duncan - Jun 16, 2024 Form 4 Insider Report for Atea Pharmaceuticals, Inc. (AVIR)

Role
Director
Signature
/s/ Andrea Corcoran, as Attorney-in-Fact for Barbara Gayle Duncan
Stock symbol
AVIR
Transactions as of
Jun 16, 2024
Transactions value $
$0
Form type
4
Date filed
6/18/2024, 05:00 PM
Previous filing
Jun 4, 2024
Next filing
Jun 21, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVIR Common Stock Options Exercise $0 +33.2K $0.00 33.2K Jun 16, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVIR Restricted Stock Units Options Exercise $0 -33.2K -100% $0.00* 0 Jun 16, 2024 Common Stock 33.2K Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 The restricted stock units are fully vested.
F3 The restricted stock units do not have an expiration date.